This roundtable discussion will include medical directors from Aetna, Cigna, United Health Care and WellPoint. The goal of the session is to discuss key issues and most importantly possible solutions. Key issues may include: quality, transparency, tier 4 drug policies, prior-authorizations and new privacy laws and violations. The session is designed to promote an honest and candid dialogue regarding the needs and operational systems of both parties, with the expectation of streamlining administrative processes to reduce time and money and effectively deliver the right care to patients and beneficiaries.
Upon completion of this session, participants should be able to:
- discuss key areas of the claims processing systems to improve efficiency and reduce denials
- identify ways to minimize the prior authorizations administrative burden for physician practices
- discuss strategies to improve the management and guidelines for the use of biologic drug therapy
|Moderators:||Rodolfo Molina, MD, Arthritis Associates PA and Alex Limanni, MD, Arthritis Centers of Texas|
To see other sessions for this day, use the date buttons to the left.